我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

雌激素与缺血性心脏病(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2004年第4期
页码:
375-380
栏目:
综述
出版日期:
2004-07-01

文章信息/Info

Title:
Estrogen and ischemic heart disease
作者:
刘冰1; 石刚刚1; 赵志青2
1.汕头大学医学院药理学教研室，广东汕头515041,2.艾默雷大学医学院卡莱尔·弗莱舍心脏中心心胸研究实验室 ，美国乔治亚州亚特兰大
Author(s):
LIU Bing1; SHI Gang -gang1; ZHAO Zhi-ging2
1. Department of Pharmacology, Shantou University Medical College, Shantou, Guangdong 515041，China; 2. Cardiothoracic Research Laboratory,Carlyle Fraser Heart Center/Crawford Long Hospital,Emory University School of Medicine ,Atlanta, Georgia,USA
关键词:
雌激素; 缺血性心胜病; 再灌注损伤; 炎性反应
Keywords:
estrogen; ischemic heart disease; reperfusion injury; inflammatory response
分类号:
R542.22
DOI:
-
文献标识码:
A
摘要:
以往的临床观察证实，生育年龄的女性缺血性心脏病的发病率和死亡率明显低于同龄男性。绝经后的妇女服用雌激素与不服用雌激素相比，前者心脏病事件少于后者.尽管临床的观察结果还有争议，越来越多的临床前期研究表明，雌激素对缺血性心脏病具有保护作用。研究结果显示，雌激素和其受体调节器是通过减少炎性反应在缺血/再灌注引起心肌损伤时起保护作用的.本文作者就近年的一些研究结果作一综述，并就雌激素替代治疗处理心肌 缺血及再灌注损伤进行探讨.
Abstract:
Prospective clinical observations have suggested that morbidity and mortality of ischemic heart disease in premenopausal women is lower than age-matched men. Exogenous administration of estrogen to postmenopausal women has shown the beneficial effects for reducing cardiovascular events over time compared with untreated women. Although there is still controversy for the final outcomes in clinical trial, a growing body of evidence from preclinical studies has demonstrated protective effects of estrogen on ischemic heart disease. This review summarizes the recent data that show protection by estrogen and its receptor modulators in attenuation of inflammation-mediated myocardial injury especially during reperfusion after ischemia. Potential future directions for using estrogen replacement therapy in treatment of heart ischemia and reperfusion injury are also discussed.

参考文献/References

[1] Verma S, Fedak PWM, Weisel RD, et al. Fundamentals of reperfusion injury for the clinical cardiologist[J ].Circulation, 2002 , 105 :2332一2336.

[2]Vittinghoff E, Shlipak MG, Varosy PD, etal.Risk factors and secondary prevention in women with heart disease.The heart and estrogen/progestin replacements tudy[J ]. Ann Intern Med , 2003,138:81一89.

[3] Tiidus PM. Oestrogen and sex influence on muscle damage and inflammation,evidence from animal models[J].Cur Opin Clin Nutr Metab Care,2001,4 :509一513.

[4] Santizo R, Anderson S, Ye S, et al. Effects of estrogen on leukocyte adhesion after transient forebrain ischemia[ J」.Stroke , 2000,31:2231一2235.

[5] Arnal JF, Bayard F. Alteration in endothelial estrogen receptor expression,A potential key of vasculoprotection by estrogens? [J] . Circ Res,2002,91:759一760.

[6] Wassmann S, Laufs U, Stamenkovic D, et al. Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production[J].Circulation, 2002 ,105:2083一2091.

[7] Ihionkhan CE, Chambliss KL, Gibson LL, et al. Estrogen causes dynamic alterations in endothelial estrogen receptor expression [J].Circ Res,2002,91:814一820.

[8] Ogita H, Node K, Asanuma H, et al. Amelioration of ischemiaand reperfusion-induced myocardial injury by the selective estrogen receptor modulartor,raloxifene,in the canine heart[J]. J Am Coll Cardiol,2002,40:998-1005.

[9] Zhao ZQ, Nakamura M, Wang NP, et al. Dynamic progression of contractile and endothelial dysfunction and infarct extension in the late phase of reperfusion[J].J Surg Res,2000,94,1 一12 .

[10]Murata M, Akao M, O'Rourke B, et al. Mitochondrial ATPsensitive potassium channelsa ttenuate matrix Ca2+ overload during simulated ischemia and reperfusion,possiblem echanism of cardioproteetion[J].Circ Res,2001,89:891一898.

[11]Kovacs EJ, Messingham KAN, Gregory MS. Estrogen regulation of immune responses after injury[J].Mol Cell Endocrinol, 2002 , 193:129一135.

[12]Wei M, Kuukasjarvi P, Laurikka J, et al. Inflammatory cytokines and soluble receptors after coronary artery bypass grafting [J ]. Cytokine,2001,15:223一228.

[13]Yen CH,HsiehCC,Chou SY,et al .17β-estradiol inhibits oxidized low density lipoprotein-induced generation of reactive oxygen species in endothelial cells[J].Life Sci,2001，70:403一413 .

[14] Liao SL, Chen WY, Chen CJ. Estrogen attenuates tumor necrosis factor-a expression to provide ischemic neuroprotection in female rats[J].Neurosci Lett,2002,330:159-162.

[15]Molero L, Garcia-Duran M, Diaz-Recasens J, et al. Expression of estrogen receptor subtypes and neuronal nitric oxide synthase in neutrophils from women and men,Regulation by estrogen [J] . Cardiovas Res,2002,56:43-51.

[16]Colacurci N, Manzella D, Fornaro F, et al. Endothelial function and menopause:effects of raloxifene ad ministration[J].J Clin Endocrinol Metab,2003,88:2135一2140.

[17]Piercy KT, Donnell RL, Kirkpatrick SS, et al. Effects of estrogen, progesterone,and combination exposure on interleukin- 1β-induced expression of VCAM-1,ICAM-1,PECAM,and E-selectin by human female Iliac artery endothelial cells[J].J Surg Res,2002,105,215一219.

[18]Beer S, Reincke M, Kral M, et al. Susceptibility to cardiac ischemia/ reperfusion injury is modulated by chronic estrogen status[J ]. J Cardiovasc Pharmacol,2002,40:420-428.

[19]Zhai PY, Eurell TE, Cotthaus R, et al. Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats[J]. Am J Physilo Heart Circ Physiol,2000,279:H 2766一H2775.

[20]Zhai PY, Eureil RE, Cooke PS, et al. Myocardial ischemiareperfusion injury in estrogen receptor-alpha knockout and wild-type mice[J].Am J Physiol Heart Circ Physiol,2000,278: H1640-H1647.

[21]McCullough LD, Alkayed NJ, Traystman RJ, et al. Postischemic estrogen reduces hypoperfusion and secondary ischemia after experimental stroke[J].Stroke,2001,32:796一802.

[22]Li HY, Wu XQ, Ye BL. Effects of estrogen replacement therapy on dislipidemia and insulin resistance in postmenopausal women with CHD[J].Chin Heart J ,2001,13(4):296一298.

[23]Gao Z, Zhu MZ, Zhou JJ, et al. Effect of estrogen on L-type calcium current in rat ventricular myocytes[J].Chin Heart J , 2003 , 15(5):385一431.

[24]Chou ET, Schulman SP, Thiemann DR, et al. Effect of shortterm estrogen with and without progesterone therapy on circulating makers of endothelial activation and injury in postmenopausal women with unstable angina pectoris[ J].Am J Cardiol,2003,91:1240-1242.

备注/Memo

备注/Memo:
收稿日期：2003-12-25
更新日期/Last Update: 2004-07-01